跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
修美乐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Adalimumab Solution for Injection
Approved
生物制品
Adalimumab Solution for Injection
ABBVIE LTD
🇨🇳 National Medical Products Administration
Approval Date
Aug 14, 2019
Approval ID
7MazXbSylbD
Company
ABBVIE LTD
Type
生物制品
Approval Details
Approval Id
7MazXbSylbD
Approval Number
S20170019
Generic Name
阿达木单抗注射液
Generic Name En
Adalimumab Solution for Injection
Trade Name
修美乐
Brand Name
修美乐
Drug Type
生物制品
Dosage Form
注射剂
Strength
40mg/0.8ml
Reg Date
2019-08-14
Expired Date
2024-08-13
Company Name
ABBVIE LTD
Company Address
Maidenhead,SL6 4UB,United Kingdom
Production Company Name
vetter pharma-fertigung gmbh & co.kg
Production Company Address
Schützenstrasse 87 and 99-101,88212 Ravensburg, Germany
Company Detail Path
/organization/abbvie-ltd-united-kingdom
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 14, 2019
Approval ID
7MazXbSylbD
Type
生物制品
Back to NMPA Approvals